The antigen specificity (e.g., autoantigens and/or EBV proteins) and the potential role of intra-lesional CD8+ T cells (cytotoxic or regulatory) in MS pathology is still a matter of debate [3, 22, 41, 54]. The gene discussed is CD8A; the disease is myeloid sarcoma.